Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Why Is Biodexa (BDRX) Up 70% Today?

By Josh Enomoto, InvestorPlace Contributor

Oncology specialist Biodexa inked a compelling licensing deal to treat a serious disease, and BDRX stock popped sharply higher.

AMC Stock: Lenders Push for AMC Debt Extension

By Josh Enomoto, InvestorPlace Contributor

While AMC Entertainment may be negotiating its debt payments, AMC stock still faces the broader box office conundrum.

Diversification Dynamos: 3 ETFs to Instantly Fortify Your Portfolio

By Josh Enomoto, InvestorPlace Contributor

With the market signaling broader challenges ahead, investors may be best served with ETFs to buy for diversification.

The Top 3 Vegan Stocks to Buy in April 2024

By Josh Enomoto, InvestorPlace Contributor

When it comes to top vegan stocks, a generational divide may prevent investors from considering the space. Let me try to persuade you to think…

Black Gold Rush: 7 Oil Stocks Poised to Surge on Geopolitical Shockwaves

By Josh Enomoto, InvestorPlace Contributor

At the moment, targeting oil stocks might not seem the most compelling idea. While the earlier flashpoint in the Middle East – with Iran and…

Load More